Aligos Therapeutics Inc. (ALGS) PT Lowered to $6 at JPMorgan
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Price: $6.89 +1.77%
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Eric Joseph lowered the price target on Aligos Therapeutics Inc. (NASDAQ: ALGS) to $6.00 (from $12.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
